| Company/Division name | Cirrus Pharmaceuticals |
| Parent company | Kemwell Biopharma |
| Type of work | Manufacturing |
| If manufacturing, is the company a contract manufacturer? | Yes |
| Reshoring category: | Transplant |
| Total number of jobs (added or to be added): | 4 |
| Year reshoring announced: | 2014 |
| Year reshoring implemented or to be implemented: | 2014 |
| Domestically, the work will be done: | In-house |
| Country(ies) from which reshored: | India |
| City reshored to: | Morrisville |
| State(s) reshored to: | NC |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | Clinical Scale Pharmaceuticals |
| What domestic positive factors made reshoring more attractive? | Customer responsiveness improvement, Manufacturing/engineering joint innovation (R&D), Re-design of the part, Other, Proximity to Market |
